Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Testicular Neoplasms 1 Testicular Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Lymphoma, B-Cell 1 Gonadal Disorders 1

Interventions

Nivolumab 2 fludarabine 1 eltrombopag 1 avelumab 1 Immunotherapy, Adoptive 1 Cyclophosphamide 1 CTL019 chimeric antigen receptor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma, B-Cell × avelumab × Clear all

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡